These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36137402)

  • 1. A MCL-1-targeted photosensitizer to combat triple-negative breast cancer with enhanced photodynamic efficacy, sensitization to ROS-induced damage, and immune response.
    Huang K; Yao H; Yan M; Zhang H; Yuan G; Wang Q; Xue J; Li J; Chen J
    J Inorg Biochem; 2022 Dec; 237():111997. PubMed ID: 36137402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phthalocyanine-based photosensitizer for effectively combating triple negative breast cancer with enhanced photodynamic anticancer activity and immune response.
    Huang K; Yan M; Zhang H; Xue J; Chen J
    Eur J Med Chem; 2022 Nov; 241():114644. PubMed ID: 35939997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photosensitive small extracellular vesicles regulate the immune microenvironment of triple negative breast cancer.
    Ding YN; Ding HY; Li H; Yang R; Huang JY; Chen H; Wang LH; Wang YJ; Hu CM; An YL; Zhang ZY; Yu WP; Tang QS; Shao GL
    Acta Biomater; 2023 Sep; 167():534-550. PubMed ID: 37302734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid cell leukemia-1 is an important apoptotic survival factor in triple-negative breast cancer.
    Goodwin CM; Rossanese OW; Olejniczak ET; Fesik SW
    Cell Death Differ; 2015 Dec; 22(12):2098-106. PubMed ID: 26045046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Novel Nanoplatform for Effective Synergistic Chemo-Photodynamic Therapy of Breast Cancer by Enhancing DNA Damage and Disruptions of Its Reparation.
    Huang Z; Xian T; Meng X; Hu H; Gao L; Huang J; Yang D; Ou K; Wang B; Zhang Y
    Molecules; 2023 Oct; 28(19):. PubMed ID: 37836815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-targeting of tumor cells and subcellular endoplasmic reticulum
    Ma K; Diao H; Xu X; Jin Y; Qiu M; Liu Z; Yang C; Zhao J; Chai S; Fang Q; Guo Z; Cui C; Xu J; Yin L; Ma HY
    Nanoscale; 2024 Jun; 16(25):12095-12106. PubMed ID: 38819371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCG2 transporter inhibitor restores the sensitivity of triple negative breast cancer cells to aminolevulinic acid-mediated photodynamic therapy.
    Palasuberniam P; Yang X; Kraus D; Jones P; Myers KA; Chen B
    Sci Rep; 2015 Aug; 5():13298. PubMed ID: 26282350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
    Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
    Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin-Targeting and Cathepsin B-Activatable Theranostic Nanoprobe for MR/Fluorescence Imaging and Enhanced Photodynamic Therapy for Triple Negative Breast Cancer.
    Wang Y; Jiang L; Zhang Y; Lu Y; Li J; Wang H; Yao D; Wang D
    ACS Appl Mater Interfaces; 2020 Jul; 12(30):33564-33574. PubMed ID: 32633941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aggregation-Induced Emission Photosensitizer Synergizes Photodynamic Therapy and the Inhibition of the NF-κB Signaling Pathway to Overcome Hypoxia in Breast Cancer.
    Wang J; Wu H; Zhao Q; Zou Y; Ding D; Yin H; Xu H
    ACS Appl Mater Interfaces; 2022 Jul; 14(26):29613-29625. PubMed ID: 35729075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theranostics of Triple-Negative Breast Cancer Based on Conjugated Polymer Nanoparticles.
    Jin G; He R; Liu Q; Dong Y; Lin M; Li W; Xu F
    ACS Appl Mater Interfaces; 2018 Apr; 10(13):10634-10646. PubMed ID: 29323875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound-targeted photodynamic and gene dual therapy for effectively inhibiting triple negative breast cancer by cationic porphyrin lipid microbubbles loaded with HIF1α-siRNA.
    Sun S; Xu Y; Fu P; Chen M; Sun S; Zhao R; Wang J; Liang X; Wang S
    Nanoscale; 2018 Nov; 10(42):19945-19956. PubMed ID: 30346453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of verteporfin-photodynamic therapy with 5-aza-2'-deoxycytidine enhances the anti-tumour immune response in triple negative breast cancer.
    Banerjee SM; Acedo P; El Sheikh S; Harati R; Meecham A; Williams NR; Gerard G; Keshtgar MRS; MacRobert AJ; Hamoudi R
    Front Immunol; 2023; 14():1188087. PubMed ID: 38022682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remotely Phototriggered, Transferrin-Targeted Polymeric Nanoparticles for the Treatment of Breast Cancer.
    Jadia R; Kydd J; Rai P
    Photochem Photobiol; 2018 Jul; 94(4):765-774. PubMed ID: 29427385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Photoactive Molecules for Targeted Therapy of Triple-Negative Breast Cancer.
    Dias CJ; Helguero L; Faustino MAF
    Molecules; 2021 Dec; 26(24):. PubMed ID: 34946732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlorin Conjugates in Photodynamic Chemotherapy for Triple-Negative Breast Cancer.
    Isaac-Lam MF
    Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitro-fatty acid inhibition of triple-negative breast cancer cell viability, migration, invasion, and tumor growth.
    Woodcock CC; Huang Y; Woodcock SR; Salvatore SR; Singh B; Golin-Bisello F; Davidson NE; Neumann CA; Freeman BA; Wendell SG
    J Biol Chem; 2018 Jan; 293(4):1120-1137. PubMed ID: 29158255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune/Hypoxic Tumor Microenvironment Regulation-Enhanced Photodynamic Treatment Realized by pH-Responsive Phase Transition-Targeting Nanobubbles.
    Zhao M; Yang X; Fu H; Chen C; Zhang Y; Wu Z; Duan Y; Sun Y
    ACS Appl Mater Interfaces; 2021 Jul; 13(28):32763-32779. PubMed ID: 34235912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel mechanism for reversal of doxorubicin-induced chemotherapy resistance by TXNIP in triple-negative breast cancer via promoting reactive oxygen-mediated DNA damage.
    Chen Y; Feng X; Yuan Y; Jiang J; Zhang P; Zhang B
    Cell Death Dis; 2022 Apr; 13(4):338. PubMed ID: 35414060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.